Studies have shown that the PTP1B gene is abnormally highly expressed in ovarian cancer, gastric cancer, prostate cancer, and breast cancer and is associated with poor prognosis (Hoekstra et al., 2016; Wang et al., 2018; Xu et al., 2019; Yu et al., 2019). This evidence concerns the gene PTPN1 and ovarian carcinoma.